Gilder Gagnon Howe & Co. LLC Has $85.15 Million Stock Position in Oscar Health, Inc. (NYSE:OSCR)

Gilder Gagnon Howe & Co. LLC boosted its stake in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 51.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,335,862 shares of the company's stock after purchasing an additional 2,151,256 shares during the period. Gilder Gagnon Howe & Co. LLC owned approximately 2.56% of Oscar Health worth $85,154,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Lingotto Investment Management LLP acquired a new stake in Oscar Health in the 4th quarter valued at $2,543,000. GDS Wealth Management grew its stake in shares of Oscar Health by 1,545.3% during the fourth quarter. GDS Wealth Management now owns 345,817 shares of the company's stock valued at $4,648,000 after acquiring an additional 324,798 shares in the last quarter. Victory Capital Management Inc. grew its stake in shares of Oscar Health by 296.0% during the fourth quarter. Victory Capital Management Inc. now owns 231,059 shares of the company's stock valued at $3,105,000 after acquiring an additional 172,706 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. acquired a new stake in shares of Oscar Health during the fourth quarter valued at about $5,672,000. Finally, Nordea Investment Management AB acquired a new stake in shares of Oscar Health during the fourth quarter valued at about $1,056,000. 75.70% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Separately, Wells Fargo & Company downgraded Oscar Health from an "overweight" rating to an "equal weight" rating and lowered their target price for the company from $20.00 to $16.00 in a research note on Thursday, March 13th. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating, two have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, Oscar Health has an average rating of "Hold" and an average target price of $20.21.

Oscar Health Stock Performance

OSCR stock traded up $0.52 during trading on Tuesday, reaching $13.14. 5,276,733 shares of the company's stock were exchanged, compared to its average volume of 3,906,694. Oscar Health, Inc. has a 1-year low of $11.20 and a 1-year high of $23.79. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. The company's fifty day moving average price is $13.49 and its 200-day moving average price is $14.76. The firm has a market cap of $3.29 billion, a PE ratio of -656.67 and a beta of 1.75.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its earnings results on Tuesday, February 4th. The company reported ($0.62) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.55) by ($0.07). Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. On average, research analysts expect that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.